The Impact of <i>MGMT</i> Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma

<i>Background and objective:</i> Despite recent advances in treatment, glioblastoma (GBM) remains the most lethal and aggressive brain tumor. A continuous search for a reliable molecular marker establishes the methylation status of the O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) gene promot...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nikola Jovanović, Tatjana Mitrović, Vladimir J. Cvetković, Svetlana Tošić, Jelena Vitorović, Slaviša Stamenković, Vesna Nikolov, Aleksandar Kostić, Nataša Vidović, Miljan Krstić, Tatjana Jevtović-Stoimenov, Dušica Pavlović
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2019-02-01
Col·lecció:	Medicina
Matèries:	glioblastoma <i>MGMT</i> methylation temozolomide overall survival prognosis methylation-specific polymerase chain reaction (MSP)
Accés en línia:	https://www.mdpi.com/1010-660X/55/2/34
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!